NEW YORK , Oct. 7, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global coronavirus test kits market in North America size is estimated to grow by USD -1.41 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of over -71.7% during the forecast period. Integration of covid-19 testing with routine healthcare check-ups is driving market growth, with a trend towards launch of new covid-19 test kits.
However, easy availability of counterfeit covid-19 test kits poses a challenge. Key market players include Abbott Laboratories, Advaite Inc., Becton Dickinson and Co.
, Biomedomics Inc, bioMerieux SA, Cellex Inc., Co Diagnostics Inc, Cue Health Inc., Danaher Corp.
, DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc.
, Laboratory Corp. Of America Holdings, Mammoth Biosciences Inc., MyBioSource Inc.
, QIAGEN N.V., QuidelOrtho Corp.
, RayBiotech Life Inc., Robert Bosch GmbH, Sherlock Biosciences, Talis Biomedical Corp, and Thermo Fisher Scientific Inc..
Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View the snapshot of this report Market Driver The coronavirus test kits market in North America is experiencing significant growth due to the ongoing research and development of COVID-19 vaccines and tests. Product quality and visibility are crucial factors driving sales.
Vendors are promoting test kits through websites and awareness programs. Notably, several res.
